Case Study: World’s Leading Pharmaceutical Company improves pharmacovigilance with Genpact Cora PharmacoVigilance

How a life sciences giant is protecting patients by transforming pharmacovigilance

World’s Leading Pharmaceutical Company, one of the world’s leading pharmaceutical companies operating in over 100 countries, was struggling to manually process adverse event (AE) cases. The work was time-consuming and inefficient, and rising case volumes made it clear they needed a more scalable, AI-driven pharmacovigilance approach. Genpact was selected as a technology partner to help modernize this critical process, using its Cora PharmacoVigilance solution.

Genpact implemented Cora PharmacoVigilance, part of its PVAI suite, to read text, understand speech, extract data from documents, identify AE signals, and learn in real time. The solution improved automation and accuracy in AE case processing, with teams set to manage cases with 50% less effort while producing more consistent AE data. Genpact’s platform also positioned the company to better predict and prevent safety issues, helping protect patients more effectively.